Drug Trials Snapshot: LYTGOBI (futibatinib)

https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshot-lytgobi LYTGOBI is a drug used for the treatment of adults with a type of bile duct cancer (intrahepatic cholangiocarcinoma) that has spread to other parts of the body (metastatic) or cannot not be removed by surgery (unresectable). It should be used in patients who have been previously treated with chemotherapy and whose cancer has a certain type of abnormality in the FGFR2 gene.